October 5, 2022

MyrsMoney

Be Lively with Business

Legend Biotech Appoints Lori Macomber as Chief Economic Officer

SOMERSET, N.J.–(Organization WIRE)–Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a world biotechnology enterprise creating, manufacturing and commercializing novel therapies to handle life-threatening health conditions, now declared the advertising of Lori Macomber, CPA, to Chief Economical Officer (CFO), productive promptly. Ms. Macomber assumes the position from Dr. Ying Huang, who has been both equally CFO and Chief Government Officer (CEO) due to the fact September 2020. Dr. Huang will go on to provide as CEO of Legend Biotech.

“Lori is a extremely valued chief and strategic considered spouse that has been instrumental in creating the company’s finance firm,” reported Ying Huang, Ph.D., Main Govt Officer of Legend Biotech. “Lori possesses deep monetary and accounting knowledge and the operational working experience necessary to usher the enterprise toward sustainable advancement as we grow to be a fully professional organization and enable build very long-phrase price for all of our stakeholders.”

As CFO, Ms. Macomber will guide the company’s money operations and retain her duties as the company’s principal economic and accounting officer. Because becoming a member of Legend Biotech in September 2019, Ms. Macomber has served as Vice President of Finance and Vice President of Provide Chain Finance and Controller.

Prior to Legend, Ms. Macomber was Organization Unit Controller at Ametek PDS, a primary supplier of components and techniques for the aerospace and defense industries. In her tenure as a finance professional, Ms. Macomber also held a variety of senior finance and accounting roles in the everyday living sciences sector, including U.S. CFO and Controller of Cello Heath and AVP Finance Web-site Leader at Eli Lilly & Corporation.

Ms. Macomber holds a Bachelor of Science in Accounting from Pennsylvania Condition University and is a qualified community accountant.

About Legend Biotech

Legend Biotech is a worldwide biotechnology company dedicated to treating, and 1 working day curing, life-threatening health conditions. Headquartered in Somerset, New Jersey, we are producing state-of-the-art cell therapies across a various array of technological know-how platforms, such as autologous and allogenic chimeric antigen receptor T-mobile, T-cell receptor (TCR-T), and natural killer (NK) mobile-dependent immunotherapy. From our a few R&D internet sites all over the environment, we use these revolutionary systems to pursue the discovery of protected, efficacious and cutting-edge therapeutics for individuals throughout the world.

Study additional at www.legendbiotech.com and adhere to us on Twitter and LinkedIn.

Cautionary Assertion:

Statements in this press release about foreseeable future expectations, strategies and prospective buyers, as perfectly as any other statements pertaining to issues that are not historic details, represent “forward-hunting statements” within the this means of The Non-public Securities Litigation Reform Act of 1995. These statements consist of, but are not minimal to, statements relating to Legend Biotech’s strategies and objectives statements relating to CARVYKTI™, including Legend Biotech’s expectations for CARVYKTI™, this sort of as Legend Biotech’s production and commercialization expectations for CARVYKTI™ and the opportunity effect of treatment with CARVYKTI™ statements about submissions for cilta-cel to, and the progress of these kinds of submissions with, the U.S. Food and Drug Administration (Food and drug administration), the European Medicines Agency (EMA), the Chinese Middle for Drug Analysis of National Medical Goods Administration (CDE) and other regulatory authorities the predicted timing of, and capability to progress, medical trials, including client enrollment the submission of Investigational New Drug (IND) purposes to, and upkeep of such programs with, regulatory authorities the potential to make, assess and current information from medical trials and the prospective benefits of Legend Biotech’s product candidates. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and very similar expressions are supposed to establish forward-on the lookout statements, though not all ahead-on the lookout statements comprise these identifying text. Actual benefits may well vary materially from all those indicated by this sort of forward-wanting statements as a end result of several important components. Legend Biotech’s expectations could be influenced by, amid other matters, uncertainties concerned in the improvement of new pharmaceutical products surprising medical trial final results, which include as a outcome of additional analysis of present clinical knowledge or unpredicted new scientific details unpredicted regulatory steps or delays, which includes requests for additional basic safety and/or efficacy info or investigation of knowledge, or authorities regulation usually unanticipated delays as a consequence of steps undertaken, or failures to act, by our third bash partners uncertainties arising from issues to Legend Biotech’s patent or other proprietary mental residence defense, such as the uncertainties associated in the U.S. litigation approach levels of competition in basic government, market, and typical community pricing and other political pressures the period and severity of the COVID-19 pandemic and governmental and regulatory measures executed in reaction to the evolving predicament as perfectly as the other aspects talked over in the “Risk Factors” part of the Legend Biotech’s Once-a-year Report submitted with the Securities and Exchange Commission on March 31, 2022. Ought to just one or much more of these hazards or uncertainties materialize, or need to underlying assumptions prove incorrect, precise results may perhaps differ materially from these described in this press release as predicted, believed, believed or anticipated.​ Any forward-on the lookout statements contained in this press launch discuss only as of the day of this press release. Legend Biotech specially disclaims any obligation to update any forward-searching assertion, regardless of whether as a result of new information and facts, potential functions or usually.